DCM Shriram reported a strong financial performance for the year ended March 31, 2026, with standalone revenue reaching ₹13,797 crore and profit after tax rising to ₹838 crore. The Board recommended a final dividend of 200% (₹4 per share), totaling 560% for the year. Additionally, the company announced a strategic ₹101 crore investment in its subsidiary, Hindusthan Speciality Chemicals, to expand its formulated resins capacity to 50,000 TPA.
Financial Highlights
DCM Shriram has delivered robust results for the fiscal year 2025-26. The company reported a total standalone revenue of ₹13,797 crore, up from ₹12,442 crore in the previous year. Profit after tax (standalone) saw significant growth, reaching ₹838 crore compared to ₹567 crore in FY2025. On a consolidated basis, the company achieved a net profit of ₹856 crore.
Dividend Payout
Reflecting the company’s strong cash flow and profitability, the Board of Directors has recommended a final dividend of 200%, amounting to ₹4 per equity share of ₹2 face value. Combined with two interim dividends of 180% each declared earlier in the year, the total dividend for FY2025-26 aggregates to 560%, or ₹11.20 per share. This payout is subject to shareholder approval at the upcoming 37th Annual General Meeting scheduled for August 18, 2026.
Strategic Expansion in Advanced Materials
The company is scaling its presence in the Advanced Materials segment through its subsidiary, Hindusthan Speciality Chemicals Limited (HSCL). The board has approved a capital investment plan of ₹101 crore to augment Formulated Resins (FR) capacity by 36,000 TPA. This initiative will bring the subsidiary’s total FR capacity to 50,000 TPA. To support this growth, the parent company will provide financial assistance of up to ₹100 crore through a mix of equity and debt.
Operational Milestones
DCM Shriram successfully commissioned a new 17,000 TPA Epichlorohydrin (ECH) plant at its Jhagadia chemical complex in Gujarat on April 1, 2026, bringing the total ECH capacity to 52,000 TPA. Additionally, the Board has approved the cancellation of 39,00,000 forfeited equity shares, streamlining the company’s capital structure subject to necessary approvals.
Source: BSE
